Does Insurance Cover GLP-1 Medications?

Does insurance cover GLP-1 medications? Sometimes. Health insurance may cover GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound, but coverage depends on the exact medication, why it’s prescribed, and the specific plan you’re enrolled in — not just the name on your insurance card.

Whether your plan pays usually comes down to:

• The specific medication (for example, Ozempic vs. Wegovy)
• The condition it’s prescribed to treat — type 2 diabetes, obesity, heart-risk reduction, sleep apnea, or another FDA-approved use
• Your insurance company and your specific plan
• The plan’s prescription formulary (its list of covered drugs)
• Prior-authorization rules (approval required before the plan pays)
• Your medical history and what’s documented in your records

That’s why two people insured by the same carrier can get completely different answers. One may have an employer plan that covers Wegovy for weight management. The other may have an individual plan from the same company that excludes weight-loss drugs entirely.

Key takeaway: GLP-1 coverage isn’t simply about whether an insurance company “covers Ozempic.” Your exact plan, diagnosis, prescription-drug formulary, and authorization requirements determine coverage.

What Are GLP-1 Medications?

GLP-1 medications are prescription drugs that copy the action of GLP-1, a hormone your gut releases after you eat. They’re used to treat type 2 diabetes and, for some brands, obesity and related conditions.

In plain English, natural GLP-1 helps with:

• Blood sugar control — it helps your body release insulin when blood sugar rises
• Insulin response — the body’s signal to move sugar out of the blood
• Digestion — it slows how quickly food leaves the stomach
• Appetite and fullness — it helps signal that you’ve had enough to eat

GLP-1 medications (the technical term is “GLP-1 receptor agonists”) act on these same pathways, but they last much longer in the body than the natural hormone.

Some newer drugs work on more than one hormone. Tirzepatide — the active ingredient in Mounjaro and Zepbound — acts on both GLP-1 and a second gut hormone called GIP. Technically that makes it a “dual agonist,” but most people, and most insurers, group it with GLP-1 medications. This article does the same.

What Are the Most Common GLP-1 Medications?

The most common GLP-1 medications in 2026 are Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda and Trulicity, plus newer daily pills: the Wegovy pill, the Ozempic pill (formerly Rybelsus) and Foundayo. The table below shows what each one is FDA-approved to treat — the detail insurers care about most.

Table 1: GLP-1 medication comparison (FDA labeling as of September 2026)

Medication	Active ingredient	How it’s typically taken	Primary FDA-approved uses	Weight-management indication?	Type 2 diabetes indication?
Ozempic (injection)	Semaglutide	Once-weekly injection	Blood sugar control in adults with type 2 diabetes; lowering heart-event risk in adults with type 2 diabetes and heart disease; lowering kidney-disease risk in adults with type 2 diabetes and chronic kidney disease	No	Yes
Ozempic pill (formerly Rybelsus)	Semaglutide	Once-daily tablet	Blood sugar control in adults with type 2 diabetes; lowering heart-event risk in high-risk adults with type 2 diabetes	No	Yes
Wegovy (injection)	Semaglutide	Once-weekly injection	Chronic weight management (adults and children 12+); lowering heart attack and stroke risk in adults with heart disease and obesity or overweight; a type of fatty liver disease (MASH) in adults	Yes	No
Wegovy pill	Semaglutide	Once-daily tablet	Chronic weight management in adults; lowering heart-event risk in adults with heart disease and obesity or overweight	Yes	No
Mounjaro	Tirzepatide	Once-weekly injection	Blood sugar control in adults with type 2 diabetes	No	Yes
Zepbound	Tirzepatide	Once-weekly injection (pen, KwikPen or vial)	Chronic weight management in adults; moderate-to-severe obstructive sleep apnea in adults with obesity	Yes	No
Foundayo	Orforglipron	Once-daily tablet	Chronic weight management in adults (approved April 1, 2026)	Yes	No (under study)
Saxenda	Liraglutide	Once-daily injection	Chronic weight management (adults and children 12+)	Yes	No
Trulicity	Dulaglutide	Once-weekly injection	Blood sugar control in type 2 diabetes (adults and children 10+); lowering heart-event risk in adults with type 2 diabetes	No	Yes

Sources: FDA-approved prescribing information for each product. Rybelsus 3 mg, 7 mg and 14 mg tablets remain on the FDA label during the transition to the Ozempic pill name. Always confirm current labeling with your prescriber or pharmacist.

Same ingredient, different brand, different coverage

Ozempic and Wegovy both contain semaglutide, while Mounjaro and Zepbound both contain tirzepatide, but the brand names have different FDA-approved indications.

That matters for insurance because plans cover drugs for specific uses, not active ingredients. A plan may cover Ozempic for type 2 diabetes but exclude Wegovy because Wegovy is approved for weight management — and the plan excludes weight-management drugs. The chemistry is similar; the benefit rules are not.

Why Does Insurance Cover a GLP-1 for One Person but Not Another?

Insurance covers a GLP-1 for one person and not another because coverage is decided plan by plan and use by use. Insurers look at the drug’s FDA-approved indication, whether it’s on the plan’s formulary, the plan’s utilization-management rules, and the patient’s documented medical history.

The diagnosis attached to the prescription can matter almost as much as the medication itself.

Example 1: Type 2 diabetes

Maria has type 2 diabetes. Her doctor prescribes Mounjaro to help control her blood sugar. Her plan covers diabetes medications, and Mounjaro is on its formulary, so it’s covered — possibly after prior authorization showing she has diabetes.

Example 2: Weight management only

James doesn’t have diabetes. His doctor prescribes Zepbound for weight management. His plan’s documents contain a line excluding “drugs used for weight loss.” Zepbound isn’t covered, even though a diabetes drug with the same active ingredient is.

Example 3: Another FDA-approved condition

Dana has moderate-to-severe obstructive sleep apnea and obesity. Zepbound is FDA-approved for that condition. Some plans that exclude weight-loss drugs will still review a request for an approved non-weight-loss use like sleep apnea or heart-risk reduction. Whether Dana’s plan does depends entirely on its policy language and criteria.

What this does not mean

A diagnosis on a prescription must reflect a patient’s actual medical condition. Never ask a prescriber to change or inaccurately code a diagnosis to get coverage — that can be insurance fraud, and it can put your coverage and your prescriber at risk. The legitimate path is to understand your plan’s criteria and, if you meet them, document that clearly.

Which Health Insurance Plans Cover GLP-1 Medications?

Every major type of health insurance can cover GLP-1 medications, but none of them guarantees it. Diabetes uses are commonly covered; weight-management uses are the ones most often limited or excluded. Here’s how each type of coverage typically works.

Table 2: How different types of insurance handle GLP-1 coverage (as of September 2026)

	Employer plan	ACA Marketplace	Private (non-Marketplace) plan	Medicare	Medicaid
Diabetes use (Ozempic, Mounjaro, Trulicity)	Commonly covered; varies by plan	Commonly covered; varies by plan	Varies widely; check the drug schedule	Usually covered by Part D plans; varies by plan formulary	Required to be covered; prior authorization common
Weight management (Wegovy, Zepbound, Foundayo, Saxenda)	May be covered; many plans exclude	Often excluded; varies by state and plan	Often limited or excluded	Not covered by standard Part D; eligible people may qualify for the $50 GLP-1 Bridge (July 2026–Dec. 2027)	Optional for states; 13 state programs covered it as of Jan. 2026
Other approved uses (heart risk, sleep apnea)	May be covered; criteria vary	May be covered; criteria vary	Varies widely	Part D plans may cover for these uses	Required to be covered
Common restrictions	Prior authorization, BMI rules, step therapy, lifestyle program	Prior authorization, step therapy, quantity limits	Drug schedules, dollar caps, exclusions	Prior authorization	Prior authorization

Employer Health Insurance

Employer coverage varies more than any other type, because the employer — not just the insurance company — decides what the prescription benefit includes.

According to KFF’s 2025 Employer Health Benefits Survey, among firms with 200 or more workers that offer health benefits, 16% of firms with 200–999 workers, 30% of firms with 1,000–4,999 workers, and 43% of firms with 5,000+ workers covered GLP-1s used primarily for weight loss in 2025. Among the largest firms covering them, 66% said the drugs had a “significant” impact on prescription spending. (KFF’s 2026 survey is expected later this fall.)

Why large employers differ from small ones:

• Self-funding. Many large employers pay claims directly (“self-funded” plans) and design their own drug lists. KFF found 80% of covered workers at larger firms are in self-funded plans.
• Small-group plans. Smaller employers usually buy a carrier’s standard plan and have fewer customization options.
• Pharmacy benefit managers (PBMs). A PBM is the company that manages the drug list and negotiates prices for the plan. Different PBMs and formularies produce different GLP-1 rules.

Common employer requirements include:

• Being on the plan’s formulary (its list of covered drugs)
• Prior authorization — plan approval before it pays
• Step therapy — trying a lower-cost option first
• BMI requirements — a minimum body mass index
• Documented weight-related conditions such as high blood pressure
• Weight-management program participation — KFF found 34% of firms covering GLP-1s for weight loss require meeting with a dietitian, case manager or therapist, or joining a lifestyle program

A UnitedHealthcare, Aetna, Cigna, Blue Cross Blue Shield, or other plan may cover a medication under one employer and exclude it under another. The employer’s benefit design matters.

ACA Marketplace Health Insurance

Marketplace plans can cover GLP-1 medications, and most cover at least some GLP-1s for type 2 diabetes. Coverage for weight management is less common. KFF notes that obesity-drug coverage remains limited in Marketplace plans, largely because of cost.

Marketplace GLP-1 coverage varies by:

• State
• Insurance company
• Specific plan (even two plans from the same insurer can differ)
• Formulary
• The reason the drug is prescribed

How to check a Marketplace plan’s GLP-1 coverage before you enroll:

1. Identify the exact medication (for example, Wegovy injection vs. Wegovy pill).
2. Find the plan’s prescription-drug formulary. On HealthCare.gov, use the prescription look-up tool while comparing plans, or open “Plan documents” in the plan details.
3. Search both the brand name and the generic name (for example, “Zepbound” and “tirzepatide”).
4. Note the drug tier — higher tiers usually cost more.
5. Look for restriction codes such as PA, ST or QL.
6. Call the insurer and confirm coverage for your specific plan.
7. Ask whether coverage differs based on diagnosis.

What the codes mean:

• PA = prior authorization. Your prescriber must get approval before the plan pays.
• ST = step therapy. You may need to try another drug first.
• QL = quantity limit. The plan caps how much it pays for in a set period.

If you depend on a particular medication, recheck coverage every year during Open Enrollment. Formularies can change from one plan year to the next.

One useful detail for Marketplace shoppers: Novo Nordisk’s savings-offer terms state that ACA Marketplace (Health Exchange) plans are not treated as government programs for its Wegovy savings offer. That means people with Marketplace coverage that covers Wegovy may be able to use the commercial copay offer, subject to its terms.

Private Health Insurance / Non-Marketplace Plans

“Private” individual coverage bought outside the Marketplace can mean very different things, and prescription benefits vary substantially. Some off-Marketplace plans are ACA-compliant and work much like Marketplace plans. Others — such as short-term plans, underwritten or limited-benefit plans, and fixed-benefit products — may have limited outpatient prescription coverage, a separate drug schedule, dollar caps, or broad exclusions for weight-loss drugs.

Don’t assume a private PPO covers GLP-1 medications because it has a well-known carrier name or a large doctor network. Before enrolling, read the actual prescription schedule, the exclusions and limitations section, and the policy or certificate of coverage.

This matters most for self-employed people comparing Marketplace coverage against private options. A lower premium can come with much thinner prescription benefits.

Medicare

2026 Medicare update (verified September 30, 2026): Standard Medicare Part D still doesn’t cover drugs used only for weight loss. But starting July 1, 2026, CMS launched the Medicare GLP-1 Bridge, a temporary program that gives eligible Part D enrollees certain GLP-1 medications for weight management at a $50 monthly copay. CMS has extended the Bridge through December 31, 2027. Details are changing quickly — confirm current rules at Medicare.gov or CMS.gov.

Medications currently included (per Medicare.gov): Wegovy (injection or pill), Foundayo (tablet), and Zepbound KwikPen only — not Zepbound single-dose vials or single-dose pens.

Who may qualify. You must have Medicare drug coverage (a stand-alone Part D plan, a Medicare Advantage plan with drug coverage, certain Special Needs Plans, employer/union group waiver plans, or LI NET). You must be 18 or older and, when starting GLP-1 therapy, meet one of these:

• BMI of 35 or higher
• BMI of 30 or higher plus heart failure with preserved ejection fraction, uncontrolled high blood pressure, or chronic kidney disease stage 3a or higher
• BMI of 27 or higher plus prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease

Who isn’t eligible. People already getting GLP-1s covered through their Part D plan, and people with type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease. For those conditions, Medicare says your regular Part D plan may cover a GLP-1 instead.

Prior authorization is required. Your provider must certify you’re using the drug alongside a diet-and-exercise lifestyle program. Approval lasts through December 31, 2027 unless you switch GLP-1s.

How the $50 works. Because the Bridge runs outside your Part D benefit, the $50 doesn’t count toward your Part D deductible or out-of-pocket limit, isn’t reduced by Extra Help, and can’t be spread out through the Medicare Prescription Payment Plan. CMS also says coupons and discount programs can’t be applied to Bridge claims.

When standard Part D rules apply instead. If a GLP-1 is prescribed for a Medicare-covered use — type 2 diabetes (Ozempic, Mounjaro, Trulicity), heart-risk reduction (Wegovy), or sleep apnea (Zepbound) — your Part D plan’s normal formulary, tiers, prior authorization and cost sharing apply.

Medicaid

Medicaid coverage of GLP-1s depends on your state and on why the drug is prescribed.

• Diabetes, heart disease and sleep apnea uses: State Medicaid programs are required to cover GLP-1 drugs approved for these conditions, though prior authorization is common, according to KFF.
• Weight management: Coverage is optional for states. KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026, down from 16 in October 2025, after California, New Hampshire, Pennsylvania and South Carolina ended coverage.
• Formularies and managed care: Each state keeps its own preferred drug list, and Medicaid managed-care plans may apply additional rules.

State policies have continued to change during 2026. Check your state Medicaid agency’s current preferred drug list, or call your Medicaid plan, rather than relying on a national list.

Why Doesn’t My Insurance Cover GLP-1 Medications for Weight Loss?

Many plans don’t cover GLP-1 medications for weight loss because of cost. The drugs are expensive, a very large share of adults could qualify, and many people take them long-term. To control spending, plans either exclude weight-loss drugs outright or cover them only with strict rules like prior authorization and BMI requirements.

1. Cost

GLP-1 prices can be confusing because there are several different “prices” for the same box of medication:

• List price — the manufacturer’s official sticker price. Novo Nordisk says it will cut the list price of Wegovy (from roughly $1,350 a month) and Ozempic to $675 a month starting January 1, 2027 (Novo Nordisk, Feb. 24, 2026).
• Negotiated insurer price — what the insurer or its pharmacy benefit manager agrees to pay the pharmacy.
• Manufacturer rebates — money the manufacturer pays back to the insurer or PBM after the fact. This is why an insurer’s actual net cost is usually lower than the list price, though those numbers are rarely public.
• Patient copay or coinsurance — your share at the pharmacy counter.
• Cash / self-pay price — what you pay outside insurance, often through a manufacturer’s direct program (see the price chart below).

Even after rebates, a drug taken every month can cost a plan thousands of dollars per member per year.

2. A large number of potential patients

About 40.3% of U.S. adults had obesity in August 2021–August 2023, according to the CDC’s National Center for Health Statistics. When a large share of members could qualify, even a moderately priced drug can add up to major spending for a plan.

3. Long-term treatment

Many people use these medications for an extended period to maintain results. Insurers price plans a year at a time, but they have to budget for members who may stay on a drug for years.

4. Weight-loss drug exclusions

Some plans simply exclude medications prescribed primarily for weight management. You’ll usually find this in the plan’s “exclusions and limitations” section, often worded as “drugs used for weight loss” or “anti-obesity medications.”

5. Utilization management

Even plans that cover GLP-1s for weight management often add rules, such as:

• Prior authorization
• A minimum BMI
• A qualifying weight-related condition (like high blood pressure)
• Step therapy (trying another option first)
• Participation in a lifestyle or coaching program
• Renewal requirements — for example, showing progress after several months

Employers report feeling this pressure directly. In KFF’s 2025 survey, 59% of the largest firms covering GLP-1s for weight loss said use was higher than expected, and among large firms not covering them, only 1% said they were “very likely” to add coverage in the next 12 months.

How Much Do GLP-1 Medications Cost With Insurance?

There’s no single GLP-1 copay. Depending on your plan, you might pay:

• A fixed copay (for example, a set amount per month)
• Coinsurance — a percentage of the drug’s negotiated price
• The full negotiated price until you meet your deductible
• A specialty-drug copay or coinsurance, if the plan puts GLP-1s on a specialty tier
• Very little after a manufacturer savings card — Novo Nordisk and Lilly both advertise as little as $25 a month for eligible commercially insured patients whose plans cover the drug
• Nothing or nearly nothing, depending on the plan and program

What drives your cost

• Prescription deductible. Some plans have a separate drug deductible; others apply the medical deductible to prescriptions. Either way, you may pay full price for a few months each year.
• Drug tier. Formularies sort drugs into tiers. Preferred brands cost less than non-preferred or specialty drugs.
• Pharmacy network. In-network pharmacies charge your plan’s rates. Out-of-network pharmacies may not be covered at all.
• Specialty pharmacy rules. Some plans require GLP-1s to be filled through a specific mail-order or specialty pharmacy.
• Manufacturer copay cards. These can cut your cost dramatically — but only if your plan covers the drug and you’re eligible. Government-program enrollees are generally excluded.

Illustrative examples (not guarantees)

These simplified examples use round numbers to show how plan design changes the monthly bill. Your actual costs will differ.

• Flat copay plan: A plan covers Wegovy on a preferred tier with a $50 copay after prior authorization. Monthly cost: about $50 — or potentially less with a manufacturer savings card, if eligible.
• High-deductible plan: A plan with a $3,000 deductible covers Zepbound, but you pay the plan’s negotiated price until the deductible is met. Your first several months could cost hundreds of dollars each before coinsurance kicks in.
• Coinsurance plan: A plan charges 30% coinsurance on specialty drugs. If the negotiated price is $1,000, you’d pay about $300 a month until you reach your out-of-pocket maximum.
• Excluded: The plan excludes weight-loss drugs. Insurance pays $0, and your options are an appeal, a manufacturer self-pay program, or a different plan at renewal.

How Much Do GLP-1 Medications Cost Without Insurance?

How much does Zepbound cost without insurance? Through Lilly’s LillyDirect self-pay program, Zepbound vials and KwikPens cost $299 a month for the 2.5 mg starting dose, $399 for 5 mg, and $449 for 7.5–15 mg if you refill within 45 days. Otherwise, higher doses cost $499–$699 a month. Prices checked September 30, 2026.

Manufacturer self-pay programs have brought cash prices far below list prices. Here’s what the official programs showed when we checked.

GLP-1 self-pay prices (checked September 30, 2026)

Medication	Typical list / cash price	Manufacturer self-pay option	Savings program if insured	Important restrictions
Wegovy pen	About $1,350/month list; $675 list planned from Jan. 1, 2027	$199/month for first 2 fills (0.25 mg and 0.5 mg, new patients, through Dec. 31, 2026), then $349/month for all doses up to 2.4 mg; Wegovy HD 7.2 mg $399/month	As little as $25/month with commercial coverage (max savings $100/month)	Through NovoCare Pharmacy or savings offer; self-pay doesn’t count toward your deductible
Wegovy pill	About $1,350/month list	$149 (1.5 mg), $199 (4 mg), $299 (9 mg and 25 mg) per month	As little as $25/month with commercial coverage	One month = 30 tablets; prices vary by dose
Ozempic injection	About $1,000/month list; $675 list planned from Jan. 1, 2027	$349/month (0.25, 0.5 or 1 mg); $499/month (2 mg)	As little as $25/month with commercial coverage (max savings $100/month)	Government-insured patients excluded from Ozempic self-pay through NovoCare Pharmacy
Zepbound	Varies by pharmacy — ask for the cash price	$299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg) per month; vial or KwikPen	As little as $25/month for single-dose pens with commercial coverage	$449 requires refill within 45 days, otherwise $499 (7.5 mg) or $699 (10–15 mg); governmental beneficiaries excluded from savings card
Foundayo	Varies by pharmacy — ask for the cash price	$149 (0.8 mg and 2.5 mg), $199 (5.5 mg), $299 (9, 14.5 and 17.2 mg) per month	As little as $25/month with commercial coverage	2.5 mg and 5.5 mg prices are temporary through Dec. 31, 2026; top doses require 45-day refills

List prices from Novo Nordisk’s February 24, 2026 announcement. Self-pay prices from NovoCare and LillyDirect as of September 30, 2026. Mounjaro, Trulicity and Saxenda cash prices vary by pharmacy; check the manufacturer’s savings page and compare pharmacies.

Advertised self-pay prices can change and may vary by:

• Dose and formulation (pen, vial, pill)
• Pharmacy (manufacturer-direct vs. retail partner)
• Eligibility and program terms
• Introductory or limited-time pricing
• Refill timing (some prices require refilling within 45 days)

Medicare.gov also points people to TrumpRx.gov to compare cash prices. It’s a price-comparison site — you can’t buy drugs directly from it.

What Can You Do If Your Insurance Doesn’t Cover Your GLP-1?

How do I get insurance to cover Wegovy? Start by finding out exactly why it isn’t covered. If your plan covers Wegovy with restrictions, your prescriber can submit prior authorization showing you meet the plan’s criteria. If it’s denied, you can appeal. If your plan excludes it entirely, compare manufacturer self-pay options and review plans at renewal.

Here’s a step-by-step plan.

Step 1: Find out why it was denied

Call your insurer or read your denial letter and ask whether:

• The drug is excluded entirely under your plan
• Prior authorization was missing or incomplete
• Your records didn’t meet the plan’s medical criteria
• Step therapy is required
• The medication is non-formulary (not on the drug list)
• The plan wants you to try a different preferred medication first

“Denied” does not always mean “never covered.” A missing form is a very different problem from a plan-wide exclusion.

Step 2: Ask your doctor about prior authorization

Prior authorization means your plan must approve the drug before it will pay. Your prescriber’s office usually submits the request. Insurers may ask for:

• Your diagnosis
• Your BMI
• Related health conditions
• Previous treatments you’ve tried
• Other medications you’ve taken

Your prescriber decides what’s medically accurate to submit. The goal is to document your real medical history clearly — not to fit a diagnosis to the plan.

Step 3: Ask about a formulary exception

If the drug isn’t on your plan’s formulary, your prescriber may request a formulary exception — asking the plan to cover a non-listed drug because it’s medically necessary for you. Approval isn’t guaranteed. If approved, you may pay the plan’s highest drug-tier cost sharing.

Step 4: Appeal a denial

You generally have three levels of review:

• Initial denial — the plan’s first decision
• Internal appeal — you ask the insurer to take a full, fair second look
• External review — an independent third party reviews the decision, when applicable. For ACA-covered plans, HealthCare.gov says you generally must request external review in writing within 4 months of the final denial, and the insurer must accept the reviewer’s decision.

Read your denial letter carefully. It should explain why coverage was denied and what appeal rights and deadlines apply. Learn more at HealthCare.gov’s guide to appealing a health plan decision.

Step 5: Check manufacturer savings programs

Novo Nordisk (Wegovy, Ozempic) and Lilly (Zepbound, Foundayo, Mounjaro) offer savings cards that can lower copays to as little as $25 a month for eligible patients whose commercial insurance covers the drug.

Watch the fine print:

• Savings cards usually require that your plan covers the drug.
• Monthly and annual savings caps apply.
• Medicare, Medicaid, TRICARE, VA and other government-program beneficiaries are commonly excluded from commercial copay cards.

Verify current eligibility directly with the manufacturer before counting on it.

Step 6: Check manufacturer self-pay programs

Manufacturers now sell some GLP-1s directly to cash-paying patients. As of September 30, 2026:

• Wegovy pen: $349/month ($199 for the first two fills for new patients at starter doses through Dec. 31, 2026)
• Wegovy pill: $149–$299/month by dose
• Zepbound: $299–$449/month by dose with on-time refills
• Foundayo: $149–$299/month by dose

Paying cash outside your health insurance generally means the expense will not count toward your health plan’s deductible or out-of-pocket maximum.

Step 7: Compare legitimate pharmacy discounts

Pharmacy discount cards and price-comparison tools can lower cash prices for some drugs. Prices can vary a lot from one pharmacy to the next, so compare several.

Two cautions: a discount card generally replaces your insurance for that prescription rather than combining with it, and what you pay usually won’t count toward your deductible.

Step 8: Review your health plan during Open Enrollment

If GLP-1 coverage matters to you, make medication coverage part of your plan comparison — not an afterthought.

Don’t just compare premiums. Compare:

• The plan’s formulary and whether your drug is on it
• The medical deductible and any separate prescription deductible
• The drug tier your medication is on
• Prior-authorization requirements
• The pharmacy network (including specialty or mail-order rules)
• The maximum out-of-pocket exposure
• Whether weight-management medications are excluded

A cheaper plan isn’t necessarily cheaper overall if you regularly take an expensive medication it doesn’t cover.

Table 3: What to do when a GLP-1 claim is denied

Reason for denial	What it means	Possible next step
Prior authorization required	The plan needs approval before it pays	Ask your prescriber to submit the PA with supporting records
Non-formulary medication	The drug isn’t on your plan’s covered list	Ask about a covered alternative or request a formulary exception
Weight-loss drugs excluded	Your plan doesn’t cover drugs for weight management	Check whether another FDA-approved use applies to you; compare self-pay options; review plans at renewal
Step therapy required	You must try another drug first	Ask your prescriber whether you’ve already met the requirement or qualify for an exception
Medical criteria not met	Your records didn’t show the plan’s required BMI or conditions	Review the plan’s criteria with your prescriber; appeal if your records support it
Quantity limit	The plan caps the amount or dose it covers	Ask your prescriber to request a quantity-limit exception if medically necessary
Specialty pharmacy requirement	The plan only pays at a designated pharmacy	Transfer the prescription to the required pharmacy

How to Check Whether Your Insurance Covers Ozempic, Wegovy, Mounjaro or Zepbound

The fastest way to check GLP-1 coverage is to call the member-services number on your insurance card with your plan details in hand. Save or copy this script.

Call script — what to say:

“I take [medication name]. Can you tell me whether it is covered under my specific plan for [medical indication]? What drug tier is it on? Does it require prior authorization, step therapy, or a quantity limit? What would my estimated cost be at an in-network pharmacy?”

Follow-up questions to ask:

• Is the deductible applied first?
• What is my copay or coinsurance?
• Is there a preferred alternative?
• Does coverage change depending on diagnosis?
• Is a specialty pharmacy required?
• Does the authorization need to be renewed — and how often?

Tip: Write down the date, the representative’s name, and a call reference number. If you’re shopping for a new plan, ask the same questions about that plan’s exact formulary for the coming plan year.

Ozempic vs. Wegovy: Why Insurance Treats Them Differently

Ozempic and Wegovy both contain semaglutide, but insurance treats them as different drugs because the FDA approved them for different uses. Ozempic is approved for type 2 diabetes and related heart and kidney risks. Wegovy is approved for chronic weight management, heart-risk reduction in people with heart disease and obesity or overweight, and a type of fatty liver disease.

Insurers build benefits around approved uses, not active ingredients. So a plan can:

• Cover Ozempic for type 2 diabetes, and
• Exclude Wegovy because the plan excludes weight-management drugs

Why does insurance cover Ozempic but not Wegovy? Usually because your plan covers diabetes drugs but excludes weight-loss drugs. The two brands also come in different doses and pens, so they aren’t interchangeable at the pharmacy.

Will insurance pay for Ozempic for weight loss? Generally, no. Weight loss isn’t an FDA-approved use for Ozempic, and many plans require prior authorization confirming type 2 diabetes. Prescribing a drug “off-label” — for a use the FDA hasn’t approved — is a medical decision for your prescriber, but it shouldn’t be used as a workaround to get insurance to pay for a weight-loss drug your plan excludes.

Mounjaro vs. Zepbound: Why Insurance Coverage Can Be Different

Mounjaro and Zepbound both contain tirzepatide, but they’re different brands with different FDA-approved uses:

• Mounjaro is approved to improve blood sugar in adults with type 2 diabetes.
• Zepbound is approved for chronic weight management in adults and for moderate-to-severe obstructive sleep apnea in adults with obesity.

Why does insurance cover Mounjaro but not Zepbound? Most often, the plan covers diabetes medications but excludes weight-management drugs. Mounjaro qualifies as a diabetes drug; Zepbound’s main use falls under the weight-loss exclusion.

Zepbound’s sleep apnea approval can create a separate path. Some plans review Zepbound for sleep apnea under different criteria than weight management — for example, requiring a documented sleep study. Whether your plan does this depends on its policy.

For Medicare, Zepbound is available through the $50 GLP-1 Bridge only as the KwikPen, and only for people who meet the program’s criteria — not for people with diagnosed sleep apnea, whose Part D plan may cover it instead.

Can You Change Health Insurance to Get GLP-1 Coverage?

Possibly. You can usually switch plans during Open Enrollment, or during a Special Enrollment Period if you have a qualifying life event such as losing other coverage, moving, marriage, or having a baby. A plan’s drug coverage changing isn’t, on its own, usually a qualifying event.

Before you switch:

• Never assume a new plan covers your medication because the carrier’s name looks familiar. The same insurer can sell plans with very different formularies.
• Verify the exact plan’s formulary for the exact plan year you’re enrolling in — not this year’s list, and not the carrier’s general list.
• Check the rules, not just the listing. Look for prior authorization, step therapy, quantity limits, and weight-loss exclusions.
• Plan for change. Formularies can change from one year to the next, so recheck every Open Enrollment.

GLP-1 Coverage for Self-Employed and 1099 Workers

If you’re self-employed, a 1099 contractor or a freelancer, nobody in an HR department is reviewing prescription benefits for you. You’re the one comparing options such as:

• Marketplace coverage
• Private individual health insurance
• A spouse’s employer plan
• COBRA from a former job
• Small-business coverage if you have employees
• Other coverage available to you

If you expect to spend hundreds of dollars a month on a prescription, compare total annual healthcare cost — premiums plus what you’ll actually pay for care and medications — not premium alone.

A simple example

Illustrative only; your numbers will differ.

• Plan A costs $100 less per month in premium, but excludes weight-management drugs. If you pay $349 a month self-pay for your medication, that’s about $4,188 a year out of pocket — and it doesn’t count toward Plan A’s deductible.
• Plan B costs $100 more per month ($1,200 more a year), but covers your medication with a $50 copay after prior authorization — about $600 a year, assuming you meet its criteria.

In this example, Plan B’s higher premium still leaves you roughly $2,400 ahead. The lowest-premium plan is not automatically the least expensive plan overall.

No agent or agency can guarantee a particular medication will be covered — coverage depends on the plan, its formulary and your prescriber’s documentation. What a good comparison can do is show you, before you enroll, which plans list your drug, on what tier, and with what restrictions.

---

Not sure whether your current health plan covers an expensive prescription?

1099 Health Insurance helps self-employed individuals, 1099 contractors, families and small-business owners compare health insurance options and understand how benefits like prescription coverage work.

• Consultations are free
• They’re brief
• There’s no pressure
• 1099 Health Insurance is licensed in 32 states

Schedule a free health insurance consultation

1099 Health Insurance can’t guarantee that any specific medication will be covered, and can’t obtain GLP-1 coverage on your behalf. We can help you compare plans and understand their prescription benefits before you choose.

---

Frequently Asked Questions About GLP-1 Insurance Coverage

Does insurance cover GLP-1 medications?

Sometimes. Many plans cover GLP-1 medications for type 2 diabetes, and some also cover them for weight management, heart-risk reduction or sleep apnea. Coverage depends on the specific drug, the reason it’s prescribed, your plan’s formulary, and rules like prior authorization. Two plans from the same insurer can have different answers.

Does insurance cover Ozempic?

Many plans cover Ozempic for adults with type 2 diabetes, often with prior authorization to confirm the diagnosis. Your cost depends on the drug tier, your deductible and your copay or coinsurance. Check your plan’s formulary or call your insurer to confirm.

Does insurance cover Ozempic for weight loss?

Usually not. Ozempic isn’t FDA-approved for weight loss, so many plans require proof of type 2 diabetes before they’ll pay. Wegovy — which contains the same active ingredient — is the semaglutide brand approved for weight management, and it has its own coverage rules.

Does insurance cover Wegovy?

Some plans do. Wegovy may be covered for weight management, for reducing heart-attack and stroke risk in people with heart disease, or for a type of fatty liver disease. Many plans exclude weight-loss drugs or require prior authorization, BMI criteria, or program participation.

Does insurance cover Zepbound?

Some plans cover Zepbound for weight management, and some review it separately for moderate-to-severe obstructive sleep apnea in adults with obesity. Plans that exclude weight-loss drugs may deny it. Expect prior authorization in most cases.

Does insurance cover Mounjaro?

Many plans cover Mounjaro for adults with type 2 diabetes, often with prior authorization. It isn’t FDA-approved for weight management, so plans generally won’t cover it for weight loss alone.

Why does my insurance cover Ozempic but not Wegovy?

Because insurers cover drugs for specific approved uses. Ozempic is approved for type 2 diabetes; Wegovy is approved mainly for weight management. If your plan covers diabetes drugs but excludes weight-loss drugs, it may cover one and not the other.

Why does my insurance cover Mounjaro but not Zepbound?

Same reason. Mounjaro is approved for type 2 diabetes, while Zepbound is approved for weight management and sleep apnea. A plan that excludes weight-loss drugs may cover Mounjaro but deny Zepbound.

How much does Wegovy cost without insurance?

As of September 30, 2026, NovoCare lists the Wegovy pen at $349 a month, with $199 a month for the first two fills for new patients at starter doses through December 31, 2026. The Wegovy pill costs $149–$299 a month depending on dose.

How much does Zepbound cost without insurance?

Through LillyDirect, Zepbound vials and KwikPens cost $299 a month (2.5 mg), $399 (5 mg), and $449 (7.5–15 mg) when refilled within 45 days, as of September 30, 2026. Without on-time refills, higher doses cost $499–$699.

How much does Ozempic cost without insurance?

Novo Nordisk’s self-pay price for Ozempic injection is $349 a month for the 0.25 mg, 0.5 mg and 1 mg doses, and $499 a month for 2 mg. Government-insured patients are excluded from Ozempic self-pay through NovoCare Pharmacy. Retail prices without a program are much higher.

Can I use a manufacturer coupon if my insurance doesn’t cover GLP-1 medications?

Commercial copay cards generally require that your plan covers the drug. If it doesn’t, you can usually use the manufacturer’s self-pay program instead, which sets a fixed cash price. Government-program beneficiaries are commonly excluded from copay cards, though some self-pay programs allow them to pay cash outside their coverage.

Can Medicare cover GLP-1 medications?

Yes, in two ways. Part D plans may cover GLP-1s for type 2 diabetes, heart-risk reduction or sleep apnea. And since July 1, 2026, the Medicare GLP-1 Bridge lets eligible Part D enrollees get Wegovy, Foundayo or the Zepbound KwikPen for weight management at $50 a month, through December 31, 2027.

Does Medicaid cover GLP-1 medications?

Medicaid must cover GLP-1s approved for type 2 diabetes, heart disease and sleep apnea, though prior authorization is common. Coverage for weight management is optional for states — KFF counted 13 state programs covering it as of January 2026. Check your state’s current preferred drug list.

Do ACA Marketplace plans cover GLP-1 drugs?

Most Marketplace plans cover at least some GLP-1s for type 2 diabetes. Coverage for weight management is less common and varies by state, insurer and plan. Use the plan’s formulary or HealthCare.gov’s drug look-up tool before you enroll.

Does Blue Cross Blue Shield cover GLP-1 medications?

It depends on your specific plan. Blue Cross Blue Shield companies are independent and offer many plans with different formularies. Coverage also depends on your state, your employer’s benefit design (if applicable), your diagnosis and the plan year. Check your plan’s formulary or call member services.

Does UnitedHealthcare cover GLP-1 medications?

It depends on your specific plan. UnitedHealthcare plans vary by state, employer benefit design, formulary, diagnosis and plan year. One UnitedHealthcare plan may cover Wegovy while another excludes it. Verify with your plan’s formulary or member services.

Does Aetna cover GLP-1 medications?

It depends on your specific plan. Aetna’s coverage varies by plan, formulary, state, employer benefit design, diagnosis and plan year. Don’t rely on a general answer — check your own plan documents or call the number on your card.

Does Cigna cover GLP-1 medications?

It depends on your specific plan. Cigna coverage varies by plan, formulary, state, employer benefit design, diagnosis and plan year. Confirm with your plan’s formulary or member services before filling a prescription.

What does prior authorization mean for GLP-1 medications?

Prior authorization means your plan must approve the medication before it pays. Your prescriber sends information such as your diagnosis, BMI, related conditions and past treatments. Many plans also require renewal after a set period, sometimes with proof the medication is working.

What happens if insurance denies Wegovy or Zepbound?

Read the denial letter to learn why. If prior authorization was missing or incomplete, your prescriber can resubmit. If you don’t meet criteria, you can appeal if your records support it. If your plan excludes weight-loss drugs, consider manufacturer self-pay programs or a different plan at renewal.

Can I appeal a GLP-1 insurance denial?

Yes. You can usually file an internal appeal with your insurer and, if that fails, request an external review by an independent third party when applicable. Your denial letter explains your appeal rights and deadlines.

Can I buy GLP-1 medications without using insurance?

Yes, with a valid prescription. Novo Nordisk (NovoCare Pharmacy) and Lilly (LillyDirect) sell several GLP-1s directly to self-paying patients, and some retail pharmacies honor the same cash prices. Avoid unapproved or unverified online sellers.

Does paying cash for GLP-1 medication count toward my insurance deductible?

Generally, no. Paying cash through a manufacturer program or discount card happens outside your insurance, so it usually won’t count toward your deductible or out-of-pocket maximum. The same is true of the $50 Medicare GLP-1 Bridge copay.

Should I choose health insurance based on whether it covers my GLP-1 prescription?

Prescription coverage should be one important factor, but not the only one. Also weigh premiums, deductibles, provider networks, your other medications, how much care you expect to use, and overall benefits. The best plan is the one with the lowest total cost for your real needs.

Important Disclaimer

Coverage, formularies, eligibility requirements and medication prices can change. This article is for general educational purposes and is not medical advice. Always verify benefits directly with your insurance company and discuss medication decisions with a licensed healthcare professional. Prices and program rules were checked on September 30, 2026.

Sources

• CMS — Medicare GLP-1 Bridge and May 6, 2026 press release; Information for Pharmacies
• Medicare.gov — Weight loss drugs (GLP-1 Bridge eligibility and costs)
• FDA — Rybelsus and Ozempic tablets prescribing information (rev. 1/2026)
• Novo Nordisk — Wegovy prescribing information; Wegovy savings offer and self-pay pricing; Ozempic self-pay terms; Feb. 24, 2026 list-price announcement
• Eli Lilly — Zepbound prescribing information; LillyDirect Zepbound pricing; LillyDirect Foundayo pricing
• KFF — 2025 Employer Health Benefits Survey; Medicaid Coverage of and Spending on GLP-1s (Jan. 16, 2026)
• CDC/NCHS — Obesity and Severe Obesity Prevalence in Adults, Aug. 2021–Aug. 2023
• HealthCare.gov — Appealing a health plan decision; External review; Marketplace coverage and prescription drugs